Dynavax Technologies Corporation

Company Profile

Dynavax Technologies Corporation had its IPO on 2004-02-19 under the ticker symbol DVAX.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Dynavax Technologies Corporation has a staff strength of 0 employees.

Stock update

Shares of Dynavax Technologies Corporation opened at $11.54 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $11.26 - $11.8, and closed at $11.27.

This is a -3.01% slip from the previous day's closing price.

A total volume of 1,815,669 shares were traded at the close of the day’s session.

In the last one week, shares of Dynavax Technologies Corporation have increased by +2.45%.

Dynavax Technologies Corporation's Key Ratios

Dynavax Technologies Corporation has a market cap of $1.425 billion, indicating a price to book ratio of 3.509 and a price to sales ratio of 2.119.

In the last 12-months Dynavax Technologies Corporation’s revenue was $0.673 billion with a gross profit of $0.235 billion and an EBITDA of $0.267 billion. The EBITDA ratio measures Dynavax Technologies Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Dynavax Technologies Corporation’s operating margin was 39.1% while its return on assets stood at 19.7% with a return of equity of 92%.

In Q2, Dynavax Technologies Corporation’s quarterly earnings growth was a positive 4945% while revenue growth was a positive 386%.

Dynavax Technologies Corporation’s PE and PEG Ratio

Forward PE

6.36

Trailing PE

6.91

PEG

0

Its diluted EPS in the last 12-months stands at $1.63 per share while it has a forward price to earnings multiple of 6.36 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dynavax Technologies Corporation’s profitability.

Dynavax Technologies Corporation stock is trading at a EV to sales ratio of 1.815 and a EV to EBITDA ratio of 4.932. Its price to sales ratio in the trailing 12-months stood at 2.119.

Dynavax Technologies Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Dynavax Technologies Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Dynavax Technologies Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Dynavax Technologies Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Dynavax Technologies Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Dynavax Technologies Corporation paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$11.27

52-Week High

$18.63

52-Week Low

$7.26

Analyst Target Price

$24.8

Dynavax Technologies Corporation stock is currently trading at $11.27 per share. It touched a 52-week high of $18.63 and a 52-week low of $18.63. Analysts tracking the stock have a 12-month average target price of $24.8.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.